A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab

por Khunger, Monica, Velcheti, Vamsidhar
Publicado 2017

Management of patients with advanced non-small cell lung cancer: role of gefitinib

por Velcheti, Vamsidhar, Morgensztern, Daniel, Govindan, Ramaswamy
Publicado 2010

Role of immune-checkpoint inhibitors in lung cancer

por Jain, Prantesh, Jain, Chhavi, Velcheti, Vamsidhar
Publicado 2018

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

por Khunger, Arjun, Khunger, Monica, Velcheti, Vamsidhar
Publicado 2018

Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices

por Velcheti, Vamsidhar, Hu, Xiaohan, Piperdi, Bilal, Burke, Thomas
Publicado 2021

Focal lung infiltrate complicating PD-1 inhibitor use: A new pattern of drug-associated lung toxicity?

por Sehgal, Sameep, Velcheti, Vamsidhar, Mukhopadhyay, Sanjay, Stoller, James K.
Publicado 2016

Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1

por Velcheti, Vamsidhar, Hu, Xiaohan, Yang, Lingfeng, Pietanza, M. Catherine, Burke, Thomas
Publicado 2022

The current state of the art and future trends in RAS-targeted cancer therapies

por Punekar, Salman R., Velcheti, Vamsidhar, Neel, Benjamin G., Wong, Kwok-Kin
Publicado 2022

MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?

por Pozza, Daniel Humberto, De Mello, Ramon Andrade, Araujo, Raphael L.C., Velcheti, Vamsidhar
Publicado 2020

Precision therapy for RET-altered cancers with RET inhibitors

por Thein, Kyaw Z., Velcheti, Vamsidhar, Mooers, Blaine H.M., Wu, Jie, Subbiah, Vivek
Publicado 2021

Immunotherapy in non-small cell lung cancer: Past, present, and future directions

por Punekar, Salman R., Shum, Elaine, Grello, Cassandra Mia, Lau, Sally C., Velcheti, Vamsidhar
Publicado 2022

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

por Liu, Stephen V., Hu, Xiaohan, Li, Yeran, Zhao, Bin, Burke, Thomas, Velcheti, Vamsidhar
Publicado 2022

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

por Carvajal-Hausdorf, Daniel E., Mani, Nikita, Velcheti, Vamsidhar, Schalper, Kurt A., Rimm, David L.
Publicado 2017

Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United State...

por Velcheti, Vamsidhar, Patwardhan, Pallavi D., Liu, Frank Xiaoqing, Chen, Xin, Cao, Xiting, Burke, Thomas
Publicado 2018

Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data

por Velcheti, Vamsidhar, Hu, Xiaohan, Li, Yeran, El-Osta, Hazem, Pietanza, M. Catherine, Burke, Thomas
Publicado 2022

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

por Huang, Min, Lou, Yanyan, Pellissier, James, Burke, Thomas, Liu, Frank Xiaoqing, Xu, Ruifeng, Velcheti, Vamsidhar
Publicado 2017

Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images

por Wang, Xiangxue, Janowczyk, Andrew, Zhou, Yu, Thawani, Rajat, Fu, Pingfu, Schalper, Kurt, Velcheti, Vamsidhar, Madabhushi, Anant
Publicado 2017

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

por Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Publicado 2019

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

por Velcheti, Vamsidhar, Schalper, Kurt, Yao, Xiaopan, Cheng, Huan, Kocoglu, Mehmet, Dhodapkar, Kavita, Deng, Yanhong, Gettinger, Scott, Rimm, David L.
Publicado 2013

Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade

por Vaidya, Pranjal, Bera, Kaustav, Patil, Pradnya D, Gupta, Amit, Jain, Prantesh, Alilou, Mehdi, Khorrami, Mohammadhadi, Velcheti, Vamsidhar, Madabhushi, Anant
Publicado 2020